Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

NATIONAL CANCER INSTITUTE - CANCER.GOV

10X Genomics

10x Genomics’ supports multiple cancer research areas from single nucleotide and structural variant detection to single cell whole transcriptome gene expression analysis of thousands of individual cells, including paired, full-length T and B cell immune repertoire profiling. With a simplified workflow, including cutting-edge and intuitive software, effortlessly and rapidly answer cancer research questions.

10x Advantages in Cancer Research

  • Unmask Tumor Heterogeneity
  • Build a comprehensive view of tumor sub-clones and clonal evolution.
  • Map the Immune Response
  • Elucidate tumor infiltrating lymphocyte phenotypes and clonal antigen recognition within the tissue microenvironment, and research molecular and cellular responses to novel immunotherapies derived from single cell genomics’ discoveries.
  • Unravel the Tumor Microenvironment
  • Determine the identity and heterogeneity of cell types in the tumor microenvironment.
  • Better Characterize Mutations in Cancer Susceptibility Genes
  • Reveal the molecular genetic basis for cancer by accurately detecting and resolving ambiguous variants, while maintaining haplotype information.

Available through the Single-Cell and Spatial Core (SCSC)

Contact Details

Director: Mike Kelly, Ph.D.
37 Convent Dr., Rm 1042A
Bethesda, MD 20892-3729
 240-760-6301
michael.kelly3@nih.gov